Joshua M. Liao & Michael A. Fischer | Huffington Post

In the first year after the approval of sofosbuvir by the FDA, there was a rapid, widespread increase in Medicaid spending on sofosbuvir, but with substantial variation across states. READ MORE

data analysis

Early Patterns of Sofosbuvir Utilization by State Medicaid Programs

Joshua M. Liao & Mark V. Pauly | Philadelphia Inquirer (Health Cents)

The outcry and scrutiny over drug pricing policies has amplified the national debate over high specialty drug costs. Not all high-priced drugs, however, are created equal. READ MORE

Why drug prices spike and what patients can do about it

Evaluating the utilization & affordability of prescription drugs

Commentary